drugset / Trial / NCT03197064

Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General Anesthesia

NCT03197064

Phase 4 Completed 11 enrolled Stanford University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if intravenous fosaprepitant can interfere with nervous system monitoring signals in patients having surgery under general anesthesia. This medication has numerous effects on the sensory nerve transmission which can theoretically have effects on the ability to accurately measure somatosensory evoked potentials.

Timeline

Start
2018-01-01
Primary completion
2020-01-31
Completion
2020-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosaprepitant Other / unclassified 150 mg Intravenous

Indications

No indication recorded.